Ann: CEO Presentation to Bioshares Conference, page-14

Good news! Since end April, 120 patients recruited. By 23 July, 113 patients completed treatment. That means 7 or less patients have dropped out or got lost. The actual dropout number depends on how many patients were recruited in the last week of April.

Regardless, a maximum of 7 patients lost of out 120 patients recruited sounds still OK, considering 18 were forecast to be lost from 168.

So patient retention seems to be going well, and maybe that is predictive of good trial execution, where patients are getting their placebo and treatment properly.